Abstract

BackgroundGene expression is epigenetically regulated by a combination of histone modifications and methylation of CpG dinucleotides in promoters. In normal cells, CpG-rich promoters are typically unmethylated, marked with histone modifications such as H3K4me3, and are highly active. During neoplastic transformation, CpG dinucleotides of CG-rich promoters become aberrantly methylated, corresponding with the removal of active histone modifications and transcriptional silencing. Outside of promoter regions, distal enhancers play a major role in the cell type-specific regulation of gene expression. Enhancers, which function by bringing activating complexes to promoters through chromosomal looping, are also modulated by a combination of DNA methylation and histone modifications.ResultsHere we use HCT116 colorectal cancer cells with and without mutations in DNA methyltransferases, the latter of which results in a 95% reduction in global DNA methylation levels. These cells are used to study the relationship between DNA methylation, histone modifications, and gene expression. We find that the loss of DNA methylation is not sufficient to reactivate most of the silenced promoters. In contrast, the removal of DNA methylation results in the activation of a large number of enhancer regions as determined by the acquisition of active histone marks.ConclusionsAlthough the transcriptome is largely unaffected by the loss of DNA methylation, we identify two distinct mechanisms resulting in the upregulation of distinct sets of genes. One is a direct result of DNA methylation loss at a set of promoter regions and the other is due to the presence of new intragenic enhancers.Electronic supplementary materialThe online version of this article (doi:10.1186/s13059-014-0469-0) contains supplementary material, which is available to authorized users.

Highlights

  • Gene expression is epigenetically regulated by a combination of histone modifications and methylation of CpG dinucleotides in promoters

  • Loss of DNA methylation does not result in an increase in active histone marks at promoters To determine the relationship between a reduction of DNA methylation and global epigenetic marks, we performed functional genomic analyses using DNA methyltransferase (DNMT)-deficient HCT116 DKO1 cells

  • The DKO1 cell line has a bi-allelic knockout of DNMT1 and bi-allelic deletion of exons 2 to 21 of DNMT3b and is reported to have 5% of the overall DNA methylation levels relative to the parental HCT116 cell line [16]

Read more

Summary

Introduction

Gene expression is epigenetically regulated by a combination of histone modifications and methylation of CpG dinucleotides in promoters. CpG dinucleotides of CG-rich promoters become aberrantly methylated, corresponding with the removal of active histone modifications and transcriptional silencing. In addition to affecting DNA methylation, 5-AzaCR can incorporate into RNA and interrupt normal cellular processes such as ribosomal assembly and translation [14,15] It was not clear if the observed changes in transcript levels were due to changes in transcription rate from de-methylated promoters or to changes in RNA stability caused by intercalation of the 5-Aza-CR into the transcripts, affecting cellular signaling pathways due to translational defects. In order to fully understand the effects of global DNA methylation loss on the transcriptome and the epigenome at promoters and distal regulatory regions, we employed genome-wide methods for examining DNA methylation, RNA expression changes, histone modification patterns, and RNA polymerase II (RNAPII) occupancy. Many of the genes that were up-regulated in DKO1 cells via mechanisms distinct from de-methylation of promoter regions had multiple newly acquired intragenic enhancers

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call